PPN Facebook PPN Twitter PPN Instagram

Eight cases of Pediatric Acute Onset Neuropsychiatric Syndrome (PANS) with Inflammatory Bowel Disease (IBD): Immunologic Intersections

RESEARCH IMPACT:
“Eight cases of Pediatric Acute Onset Neuropsychiatric Syndrome (PANS) with Inflammatory Bowel Disease (IBD): Immunologic Intersections” reveals a strong clinical and immunologic association between PANS and IBD, indicating shared pathophysiological mechanisms and potential treatment overlap. Effective management of IBD in the highlighted cases not only controlled intestinal inflammation but also alleviated PANS related neuropsychiatric symptoms. This case series reinforces that clinicians that see children with PANS, joint complaints, and a family history of autoimmunity should have a low threshold to evaluate for gastrointestinal inflammation.

SUMMARY

“Eight cases of Pediatric Acute Onset Neuropsychiatric Syndrome (PANS) explores the intersection between Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Inflammatory Bowel Disease (IBD)”, presenting eight pediatric patients diagnosed with both conditions. All individuals in this case series were identified from Stanford Immune Behavioral Health Clinic, Cedars-Sinai Medical Center Pediatric Inflammatory Bowel Disease Program, and Dartmouth Neuroimmune Psychiatric Disorders (NIPD) Clinic.

PANS, the umbrella condition in which PANDAS falls under, was found to precede IBD in seven of the eight cases, often by many years. These patients also exhibited a high prevalence of immune-mediated comorbidities, including arthritis (63%) and eczema or asthma, along with a strikingly high incidence of first-degree relatives with psoriasis or psoriatic arthritis (71%). The study suggests shared immunological underpinnings among PANS, IBD, and other inflammatory disorders, potentially mediated by cytokine pathways such as IL-17 and TNF-α.

Notably, in 5 cases where a PANS diagnosis predated the IBD diagnosis, neuropsychiatric symptoms stabilized or improved following standard IBD therapy. This reinforces the importance of gastrointestinal and systemic immune evaluation in children presenting with PANS—particularly when accompanied by joint symptoms or a strong family history of autoimmune disease. Clinicians are encouraged to consider early immune-modulating therapy in such patients, as timely IBD management may improve both gastrointestinal and neuropsychiatric outcomes.

LINK TO PAPER: https://karger.com/dne/article-pdf/doi/10.1159/000543969/4334423/000543969.pdf

CITATION

Angela W. Tang, Paula M. Prieto Jimenez, Ian K.T. Miller, Juliette C. Madan, Jaden Nguyen, Meiqian Ma, Melissa Silverman, Bahare Farhadian, Jenny Wilson, Alka Goyal, Cindy Manko, Yinka Davies, Shervin Rabizadeh, Jennifer Frankovich; Eight Cases of Pediatric Acute-Onset Neuropsychiatric Syndrome with Inflammatory Bowel Disease: Immunologic Intersections. Dev Neurosci 2025; https://doi.org/10.1159/000543969

Eight cases of Pediatric Acute Onset Neuropsychiatric Syndrome (PANS) with Inflammatory Bowel Disease (IBD)